Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
about
Complexities in Ferret Influenza Virus Pathogenesis and Transmission ModelsAnimal models for influenza virus pathogenesis, transmission, and immunologyAcute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptidesA mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal modelResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesCompetitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in FerretsCombination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.Mapping influenza transmission in the ferret model to transmission in humans.Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar FluidThe 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical modelComparison of influenza and SIV specific CD8 T cell responses in macaquesThe R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets.In vivo fitness associated with high virulence in a vertebrate virus is a complex trait regulated by host entry, replication, and shedding.Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaquesAnalysis of host genetic diversity and viral entry as sources of between-host variation in viral loadNovel Reassortant H5N6 Influenza A Virus from the Lao People's Democratic Republic Is Highly Pathogenic in Chickens.Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new hostR292K substitution and drug susceptibility of influenza A(H7N9) viruses.Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.The role of virulence in in vivo superinfection fitness of the vertebrate RNA virus infectious hematopoietic necrosis virus.New pathogenic viruses and novel antiviral drugs.
P2860
Q26740459-BF0466B7-C41D-4444-8F8D-A9DDDE8721DBQ27024582-7CC96930-DDF2-4353-8725-95EB87CA787BQ27687391-CC718AC6-11CB-415B-A3CC-1C0EC9BB6F5BQ28477927-B2615B96-E9B7-465D-818A-85E7A9FFC762Q28535274-E663AFB2-C724-4063-8282-99FA53C2FA91Q28541953-B7C23666-8C2F-4A32-B362-9328CF0885E6Q28553195-2D82BBCA-A48C-4CD5-B77E-34A3AB22CD8EQ30364319-39DC1B23-B6D1-4649-98EF-F731B98344A1Q30378661-56AC27ED-D3DB-4F30-B7AC-780192127718Q30384874-BC060255-F1ED-4B18-B965-BBF8DDE86341Q30410229-D7B4724C-6A79-40A3-A5CA-261CE05CE2CDQ30419391-EBB70B59-E0C0-4A65-9EA1-E9D9936B5322Q30419738-F59ECBAD-1DB5-47AC-8B82-8742BA108C7EQ30421991-AF71185B-C4FF-4276-9C42-BCACBFE80C00Q30425354-47C18AB2-A439-42B8-94A6-65305E0C4BD7Q30430458-9265EEC3-51E3-4FA0-9BD7-2E15C1FDFA66Q33859412-C59DEB75-EDBE-4670-AF6C-4C3213B57535Q34189478-29BB0D04-E594-4A5C-A131-93AAEF79DB43Q34974802-92158290-B503-4CA8-8A6C-DCFCB6FDD0F5Q35076523-4E00B9A2-0C20-4D84-8293-F5F3B1B62890Q35364037-F51A06DF-7290-4466-B3B8-43D07BF9DD51Q35857016-F195FD00-7FB8-4842-8EE1-76F664D6B5CEQ36134067-424C8084-942C-4156-BF07-F834CBE9B2B4Q36760138-AFF111BE-F25C-4036-A869-DFD3F7AB0551Q37262432-B508E008-F380-4D2F-A53E-A044F7374604Q37331091-A3745E95-5AAD-48A2-87E4-BC0BABCD1F22Q38209673-944B390F-9990-411E-B0AB-3A14983290AFQ40004651-03411BE7-0A10-4FA1-BF2C-A5AC6127DB4AQ40138039-C98E53F9-90DF-4A82-BC9A-440E6E053342Q41095623-8B37E89B-95E2-42CD-8174-06C9AFD5D00BQ41973717-E065E6ED-49CA-4D2F-9E60-7335FFB42927Q51054451-BF45711C-B4BC-4ED8-9588-5AEC40C33970
P2860
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessing the viral fitness of ...... a competitive-mixtures model.
@ast
Assessing the viral fitness of ...... a competitive-mixtures model.
@en
Assessing the viral fitness of ...... a competitive-mixtures model.
@nl
type
label
Assessing the viral fitness of ...... a competitive-mixtures model.
@ast
Assessing the viral fitness of ...... a competitive-mixtures model.
@en
Assessing the viral fitness of ...... a competitive-mixtures model.
@nl
prefLabel
Assessing the viral fitness of ...... a competitive-mixtures model.
@ast
Assessing the viral fitness of ...... a competitive-mixtures model.
@en
Assessing the viral fitness of ...... a competitive-mixtures model.
@nl
P2093
P2860
P50
P356
P1433
P1476
Assessing the viral fitness of ...... a competitive-mixtures model.
@en
P2093
Angela R McLean
Helen R Fryer
Jennifer Mosse
Siti Sarah Nor'e
P2860
P304
P356
10.1128/JVI.00373-10
P407
P577
2010-07-14T00:00:00Z